Biomedical Engineering Reference
In-Depth Information
163. Gonzalez L, Lison D, Kirsch-Volders M. Genotoxicity of engineered nanomaterials: A critical review.
Nanotoxicology
. 2008;2(4):252-73.
164. Sargent LM, Reynolds SH, Castranova V. Potential pulmonary effects of engineered carbon nanotubes:
In vitro
genotoxic effects.
Nanotoxicology
. 2010;4(4):396-408.
165. Sargent L, Shvedova A, Hubbs A, Salisbury J, Benkovic S, Kashon M et al. Induction of aneuploidy by
single-walled carbon nanotubes.
Environmental and Molecular Mutagenesis
. 2009;50(8):708-17.
166. Asakura M, Sasaki T, Sugiyama T, Takaya M, Koda S, Nagano K et al. Genotoxicity and cytotoxicity
of multi-wall carbon nanotubes in cultured Chinese hamster lung cells in comparison with chrysotile A
fibers.
Journal of Occupational Health
. 2010(0):1003290122.
167. Muller J, Decordier I, Hoet PH, Lombaert N, Thomassen L, Huaux F et al. Clastogenic and aneugenic
effects of multi-wall carbon nanotubes in epithelial cells.
Carcinogenesis
. 2008;29(2):427-33.
168. Shvedova AA, Kisin E, Murray AR, Johnson VJ, Gorelik O, Arepalli S et al. Inhalation vs. aspiration of
single-walled carbon nanotubes in C57BL/6 mice: Inflammation, fibrosis, oxidative stress, and mutagene-
sis.
American Journal of Physiology—Lung Cellular and Molecular Physiology
. 2008;295(4):L552-L65.
169. Pauluhn J. Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: Toxic
effects are determined by density of agglomerate structures, not fibrillar structures.
Toxicological
Sciences
. 2010;113(1):226-42.
170. Koyama S, Kim YA, Hayashi T, Takeuchi K, Fujii C, Kuroiwa N et al.
In vivo
immunological toxicity in
mice of carbon nanotubes with impurities.
Carbon
. 2009;47(5):1365-72.
171. Lam C-W, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in
mice 7 and 90 days after intratracheal instillation.
Toxicological Sciences
. 2004;77(1):126-34.
172. Muller J, Huaux F, Lison D. Respiratory toxicity of carbon nanotubes: How worried should we be?
Carbon
. 2006;44(6):1048-56.
173. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI et al. Unusual inflammatory
and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice.
American Journal of
Physiology—Lung Cellular and Molecular Physiology
. 2005;289(5):L698-L708.
174. Carrero-Sanchez J, Elias A, Mancilla R, Arrellin G, Terrones H, Laclette J et al. Biocompatibility and
toxicological studies of carbon nanotubes doped with nitrogen.
Nano Letters
. 2006;6(8):1609-16.
175. Zhu M-T, Feng W-Y, Wang B, Wang T-C, Gu Y-Q, Wang M et al. Comparative study of pulmonary
responses to nano-and submicron-sized ferric oxide in rats.
Toxicology
. 2008;247(2):102-11.
176. Brown T. Silica exposure, smoking, silicosis and lung cancer—complex interactions.
Occupational
Medicine
. 2009;59(2):89-95.
177. De Jong WH, Borm PJ. Drug delivery and nanoparticles: Applications and hazards.
International Journal
of Nanomedicine
. 2008;3(2):133.
178. Bhattacharya K, Davoren M, Boertz J, Schins R, Hoffmann E, Dopp E. Titanium dioxide nanoparticles
induce oxidative stress and DNA-adduct formation but not DNA-breakage in human lung cells.
Part
Fibre Toxicology
. 2009;6:17.
179. AshaRani P, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver
nanoparticles in human cells.
ACS Nano
. 2009;3(2):279-90. Epub 2009/02/25.
180. Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain drug
delivery.
Advanced Drug Delivery Reviews
. 2007;59(6):454-77.
181. Grabowski N, Hillaireau H, Vergnaud J, Aragao LS, Kerdine-Romer S, Pallardy M et al. Toxicity of
surface-modified plga nanoparticles towards lung alveolar epithelial cells.
International Journal of
Pharmaceutics
. 2013;454:686-694.
182. McClements DJ. Edible lipid nanoparticles: Digestion, absorption, and potential toxicity.
Progress in
Lipid Research
. 2013;52:409-423.
183. Thakore S, Valodkar M, Soni JY, Vyas K, Jadeja RN, Devkar RV et al. Synthesis and cytotoxicity evalu-
ation of novel acylated starch nanoparticles.
Bioorganic Chemistry
. 2013;46:26-30.
184. Termsarasab U, Cho H-J, Kim DH, Chong S, Chung S-J, Shim C-K et al. Chitosan oligosaccharide-
arachidic acid-based nanoparticles for anti-cancer drug delivery.
International Journal of Pharmaceutics
.
2012;441:373-380.
185. Xu Q, Wang C-H, Pack DW. Polymeric carriers for gene delivery: Chitosan and poly (amidoamine) den-
drimers.
Current Pharmaceutical Design
. 2010;16(21):2350.
186. Vishu Kumar A, Varadaraj MC, Lalitha RG, Tharanathan R. Low molecular weight chitosans: Preparation
with the aid of papain and characterization.
Biochimica et Biophysica Acta (BBA)—General Subjects
.
2004;1670(2):137-46.
187. Prow TW. Toxicity of nanomaterials to the eye.
Wiley Interdisciplinary Reviews: Nanomedicine and
Nanobiotechnology
. 2010;2(4):317-33.
